Juha Pekka Turunen - Concepedia

Author

Juha Pekka Turunen

University of Helsinki

Also Known As

J P Turunen, J. P. TURUNEN, J.‐P. TURUNEN, JUHA PEKKA TURUNEN, Juha P. Turunen, Juha Pekka Turunen

Publications

671

Citations

H-Index

Concepts

All Affiliations

University of Helsinki Helsinki University Hospital

About

Juha Pekka Turunen is an author at University of Helsinki specializing in immunology, medicine, and cell transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	219
2	Biomedical Engineering	2	2	38
3	Engineering	1	1	54
4	Biochemistry	1	1	54
5	Biomolecular Engineering	1	1	54

Juha Pekka Turunen

Publications

625

Citations

H-Index

Page 1

	Year	Citations
De novo expression of endothelial sialyl Lewis(a) and sialyl Lewis(x) during cardiac transplant rejection: superior capacity of a tetravalent sialyl Lewis(x) oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion. Juha Pekka Turunen, Marja‐Leena Majuri, Antti Seppo, The Journal of Experimental Medicine HistocompatibilitySlex FamilyImmunologyTransplantation MedicineSialyl Lewis	1995	101
Synthesis of a Divalent Sialyl Lewis x O‐glycan, a Potent Inhibitor of Lymphocyte‐Endothelium Adhesion Hannu Maaheimo, Risto Renkonen, Juha Pekka Turunen, European Journal of Biochemistry	1995	67
Synthesis of a new nanomolar saccharide inhibitor of lymphocyte adhesion: different polylactosamine backbones present multiple sialyl Lewis x determinants to L-selectin in high-affinity mode Ossi Renkonen, Sanna Toppila‐Salmi, Leena Penttilä, Glycobiology EngineeringGlycobiologyImmunologyEnzymatic SynthesisLymphocyte Adhesion	1997	54
Characterization of high endothelial-like properties of peritubular capillary endothelium during acute renal allograft rejection. Risto Renkonen, Juha Pekka Turunen, Juhani Rapola, PubMed	1990	52
Sialyl Lewis<sup>x</sup>‐ and L‐selectin‐dependent site‐specific lymphocyte extravasation into renal transplants during acute rejection Juha Pekka Turunen, Timo Paavonen, Marja‐Leena Majuri, European Journal of Immunology	1994	48
Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endothelium Antti Seppo, Juha Pekka Turunen, Leena Penttilä, Glycobiology	1996	48
Prognostic value of biomarkers in malignant melanoma Micaela Hernberg, Juha Pekka Turunen, Kristina von Boguslawsky, Melanoma Research	1998	38
The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy. Micaela Hernberg, Timo Muhonen, Juha Pekka Turunen, Journal of Clinical Oncology	1996	33
Tenascin‐C in primary malignant melanoma of the skin Suvi Ilmonen, Tiina Jahkola, Juha Pekka Turunen, Histopathology	2004	32
EVIDENCE THAT LYMPHOCYTE TRAFFIC INTO REJECTING CARDIAC ALLOGRAFTS IS GD11a- AND CD49d-DEPENDENT Juha Pekka Turunen, Pirkko Mattila, Jorma Halttunen, Transplantation Composite AllograftImmunologyPathologyCardiac AllograftsBiomedical Engineering	1992	27

Page 1